Form 4 for BSX Boston Scientific
Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0001225208-24-001781 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-08 | 2024-02-06 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | A - Grant | $0.00 | +26.7K | 83.3K | +47% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | F - Tax | $0.00 | -12.2K | 71.1K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-06 | A | A | 26,666 | $0.00 | 83,254 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-06 | F | D | 12,160 | $0.00 | 71,094 | D | — | — |